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Polychlorinated biphenyls (PCBs) remain an
important class of environmental contami-
nants even though major legislative measures
were taken by most industrialized countries in
the early 1970s to stop their production and
to restrict most their uses thereof (1). 2,2-
Bis(4-chlorophenyl)-1,1,1-trichloroethane
(4,4´-DDE) and persistent PCB congeners
are in general and still the most abundant
pollutants in wildlife and humans, although
recent decreases have been reported (2,3).
High concentrations of these substances have
been determined even in populations living
in remote areas (4,5), including people from
the Faroe Islands, as first documented by
analyses of four pools of human breast milk
sampled from a birth cohort in 1987 (6).
Similarly high PCB and 4,4´-DDE concen-
trations were obtained from a second Faroese
birth cohort from 1994 (7). People who have
a high consumption of fatty fish and live
closer to the sources of contamination have
high levels of PCBs and DDE (8).
Halogenated phenolic compounds
(HPCs) are known to be strongly retained in
human and wildlife blood (9), and these
metabolites may be present in concentrations
only slightly lower than those of the parent
compounds (10–12). Among those com-
pounds, a large number of polychloro-
biphenylols (OH-PCBs) have earlier been
reported in blood from humans, birds, seals,
and polar bears (9–17). The concentration of
the OH-PCBs may exceed 10% of the total
PCB concentration in human serum (5,9,12).
As many as 38 OH-PCBs have been identi-
ﬁed in human plasma (10), but only a few of
these make up the major proportion of the
OH-PCB concentrations in the human
blood. OH-PCBs are formed via cytochrome
P450-mediated oxidation of individual PCB
congeners, and those being retained in the
blood are metabolites of those that are most
strongly accumulated in lipids—the most
persistent PCB congeners. Several of the OH-
PCBs compete with thyroxine (T4) for its
binding to transthyretin (TTR) (18). One of
the major OH-PCBs, 2,3,3´,4´,5-pen-
tachloro-4-biphenylol (4-OH-CB107), which
has been identified in human blood (9),
appears to possess adverse endocrine-related
toxicity (19). OH-PCB metabolites are gener-
ally more hydrophilic than the parent com-
pound and are therefore more easily
eliminated from the body than their parent
PCB congeners. Still, the physicochemical
properties of some of the OH-PCBs suggest
retention rather than excretion (9). However,
it is not known whether the OH-PCBs occur
along with the parent PCB congeners at simi-
larly increased concentrations in subjects with
high exposure to lipophilic contaminants
from seafood as those with a lower exposure.
The Faroe Islands in the North Atlantic
have a relatively uniform population of about
45,000 inhabitants. Besides ﬁsh (mainly cod),
pilot whale blubber and meat have tradition-
ally been part of their diet (6). Seabirds and
their eggs may also be included in the Faroese
diet for part of the year. Certain types of
marine food, especially fatty ﬁsh and blubber
of mammals living in polluted waters, contain
high concentrations of organohalogen sub-
stances (OHSs) (1). Persons who frequently
consume contaminated seafood therefore
exhibit increased concentrations of OHSs in
serum and adipose tissue (8,12).
Our aim in this study was to determine
the concentrations of OH-PCBs and PCBs in
serum samples from pregnant Faroese
women. Women were therefore selected to
represent different exposure levels associated
with different intakes of traditional food.
Materials and Methods
Samples. Serum samples were collected at the
National Hospital in Tórshavn, Faroe
Islands, in connection with the formation of a
cohort of 182 mother–child pairs in
1994–1995. We collected maternal serum
samples at the last antenatal consultation,
approximately the 32nd week of pregnancy.
Milk was obtained at 3–4 days postpartum
and analyzed for major PCB congeners (7).
Based on these results, we selected 36 subjects
to represent the full range of PCB exposures.
Stored serum was retrieved for analysis. We
used a brief nutritional questionnaire to
obtain information about the frequency of
blubber and whale meat meals during preg-
nancy (number of meals per month).
Although we made no attempt to assess life-
time intake levels, we categorized the subjects
with respect to their recent consumption of
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0–1 blubber meals/month (n = 21); moder-
ate/high = 2–8 blubber meals/month (n =
15). This stratification provided reasonable
numbers of subjects in each category.
Chemicals. The reference compounds, the
abbreviations by which they are designated, and
their sources of origin are given in Table 1.
Hexane (Hx) and dichloromethane (DCM)
were pesticide grade (Fisher Scientific,
Leicestershire, UK). Potassium chloride,
hydrochloric acid, sulfuric acid (Merck,
Darmstadt, Germany), and potassium hydrox-
ide (Eka Nobel, Bohus, Sweden) were all of pro
analysis (p.a.) quality. 2-Propanol (p.a. grade;
Prolabo, Cedex, France) and methyl tert-butyl
ether (HPLC-grade; Rathburn, Walkerburn,
Scotland) were glass distilled before use. Silica
gel (< 0.063 mm) was purchased from
Macherey-Nagel (Düren, Germany) and acti-
vated before use. Deionized water was pro-
duced in an Elga stat apparatus (Elga Ltd.,
Wycombe, England). Diazomethane was
prepared from N-methyl-N-nitroso-P-toluene-
sulfonamide (Diazald) obtained from Sigma-
Aldrich (Steinheim, Germany) (20).
Instruments. We used a vacuum cen-
trifuge evaporator (Genevac SF50; Saler
Development Ltd., Ipswich, UK) to evaporate
solvents. A table centrifuge (Wifug Ltd.,
Bradford, England) operated at 3000 rpm was
used to promote efﬁcient phase separation.
Gas chromatography (GC) analyses were
performed on a Varian 3400 gas chromato-
graph, equipped with a Varian 8200 autosam-
pler (Varian Associates, Walnut Creek, CA,
USA), an electron capture detector (ECD),
and a split-splitless injector operated in the
splitless mode. Hydrogen was used as carrier
gas and nitrogen as make-up gas. For PCB
analysis a DB-5 column (30 m × 0.25 mm
internal diameter and 0.25 µm ﬁlm thickness;
J&W Scientiﬁc, Folsom, CA, USA) was used.
The GC temperature program was initiated at
80°C (2 min) and then increased by
10°C/min to 300°C (10 min). The injector
temperature was 250°C and the detector tem-
perature 360°C. The analysis on the phenolic
substances was performed on a CP-Sil 8-col-
umn (25 m × 0.15 mm internal diameter and
0.12 µm film thickness; Chrompack, EA
Middelburg, The Netherlands). The column
temperature was programmed as follows:
80°C (2 min), 50°C/min to 200°C, 1°C/min
to 230°C, and 30°C/min to 330°C (3 min).
The injector temperature was 280°C and the
detector temperature 360°C. We collected
and processed data using a PC-based ELDS
Pro v2.0 system (Chromatograhic Data
System AB, Stockholm, Sweden).
Cleanup procedure. The extraction and
cleanup procedure of the OHS from serum
has been described in detail elsewhere (21).
The surrogate standards, CB189 (4 ng) and
4-OH-CB193 (2 ng), were added before
extraction. We determined the extracted lipid
amount gravimetrically. The cleanup produced
two fractions, one containing neutral and the
other containing the phenolic substances (21).
In addition to the cleanup described in the
method, the neutral fraction was run through a
pasteur pipette column (90 mm × 4 mm inter-
nal diameter) with activated silica gel (1 g),
using hexane (5.5 mL) as the mobile phase.
The neutral fraction was further cleaned up
using a silica gel/sulfuric acid column (2:1,
w:w, 0.5 g) with hexane (8 mL) as the mobile
phase. The phenolic fraction was treated in the
same way as described by Hovander et al. (21).
Blank samples (n = 9) were run in parallel.
Recoveries of the internal surrogate standards
CB189 and 4-OH-CB193 were 83% (SD 5.1,
n = 36) and 88% (SD 9.5, n = 36), which is
in agreement with earlier studies (21).
Results
The concentrations of the major OH-PCBs,
4-OH-CB107, 3-OH-CB153, 4-OH-
CB146, 3´-OH-CB138, and 4-OH-CB187,
were added together, and median concentra-
tions and 80th percentile ranges are given in
Table 2. The ΣOH-PCB concentrations are
reported both on a fresh-weight and a lipid-
weight basis because these metabolites are not
retained in the blood lipids like their parent
compounds (Tables 2 and 3). The ΣOH-
PCB ranges in the low and moderate/high
blubber consumption groups were 19–750
ng/g lw and 25–1,800 ng/g lw, respectively.
A typical GC/ECD chromatogram for OH-
PCBs in serum from a pregnant Faroese
woman is shown in Figure 1. The structures
of the five OH-PCBs for which concentra-
tions are reported (Table 2) are superimposed
on the chromatogram. At least 20 other peaks
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Table 1. Reference substances and internal surrogate standard (IS) used for quantiﬁcation of PCBs and
OH-PCBs in the human serum samples.
Substances Abbreviationa Source
Polychlorinated biphenyls (PCBs)
2,3,3´,4,4´-Pentachlorobiphenyl CB105 b
2,3´,4,4´,5-Pentachlorobiphenyl CB118 (34)c
2,2´,3,4,4´,5´-Hexachlorobiphenyl CB138 b
2,2´,3,4´,5,5´-Hexachlorobiphenyl CB146 b
2,2´,4,4´,5,5´-Hexachlorobiphenyl CB153 (35)c
2,3,3´,4,4´,5-Hexachlorobiphenyl CB156 (35)c
2,3,3´,4,4´,5´-Hexachlorobiphenyl CB157 b
2,3´,4,4´,5,5´-Hexachlorobiphenyl CB167 b
2,2´,3,3´,4,4´,5-Heptachlorobiphenyl CB170 b
2,2´,3,3´,4,5,5´-Heptachlorobiphenyl CB172 (34)c
2,2´,3,3´,4´,5,6-Heptachlorobiphenyl CB177 (34)c
2,2´,3,3´,5,5´,6-Heptachlorobiphenyl CB178 b
2,2´,3,4,4´,5,5´-Heptachlorobiphenyl CB180 b
2,2´,3,4,4´,5´,6-Heptachlorobiphenyl CB183 (35)c
2,2´,3,4´,5,5´,6-Heptachlorobiphenyl CB187 b
2,3,3´,4,4´,5,5´-Heptachlorobiphenyl CB189 (IS) (34)c
2,2´,3,3´,4,4´,5,5´-Octachlorobiphenyl CB194 (35)c
2,2´,3,3´,4,4´,5,6-Octachlrorobiphenyl CB195 b
2,2´,3,3´,4,4´,5,6´-Octachlorobiphenyl CB196 b
Methoxy-PCBs
4-Methoxy-2,3,3´,4´,5-pentachlorobiphenyl 4-MeO-CB107 (36)c
3´-Methoxy-2,2´,3,4,4´,5´-hexachlorobiphenyl 3´-MeO-CB138 (36)c
4-Methoxy-2,2´,3,4´,5,5´-hexachlorobiphenyl 4-MeO-CB146 (36)c
3-Methoxy-2,2´,4,4´,5,5´-hexachlorobiphenyl 3-MeO-CB153 (36)c
4-Methoxy-2,2´,3,4´,5,5´,6-heptachlorobiphenyl 4-MeO-CB187 (36)c
4-Methoxy-2,3,3´,4´,5,5´,6-heptachlorobiphenyl 4-MeO-CB193 (IS) (36)c
aAbbreviation according to PCB numbering system (37); MeO-PCBs were numbered according to Letcher et al. (9).
bPromochem AB, Ulricehamn, Sweden. cSynthesized according to the reference given. 
Table 2. Concentrations (ng/g lipid weight and ng/g fresh weight) of OH-PCB congeners in serum from
pregnant women from the Faroe Islands according to recent pilot whale blubber consumption.
Concentration (ng/g lipid weight) Concentration (ng/g fresh weight)
Lowa Moderate/highb Lowa Moderate/highb
Compound Median 80%c Median 80%c Median 80%c Median 80%c
Lipid (%) 0.78 0.67–0.97 0.83 0.64–1.00
4-OH-CB107 12 5.1–73 71 41–230 0.084 0.041–0.63 0.49 0.29–1.7
3-OH-CB153 13 4.0–75 64 16–190 0.10 0.031–0.58 0.49 0.11–1.3
4-OH-CB146 23 9.8–170 120 13–270 0.15 0.081–1.4 1.1 0.14–1.8
3´-OH-CB138 13 3.5–100 96 47–170 0.11 0.033–0.84 0.64 0.34–1.4
4-OH-CB187 37 18–210 190 23–470 0.27 0.14–1.6 1.6 0.23–3.0
ΣOH-PCBd 96 39–590 560 36–1300 0.75 0.34–4.6 5.0 0.37–8.1
The OH-PCB congeners are listed in elution order on a CP-Sil 8 column. 
a0–1 meals/month. b2–8 meals/month. c80% range (10th–90th percentiles). dSum of the OH-PCBs shown. were detected, representing other OH-PCBs
and dihydroxylated PCB congeners (10).
The serum concentrations, medians, and
80th percentile ranges of 18 PCB congeners,
along with the ΣPCB (sum of detected con-
geners), are presented in Table 3. CB153
shows a concentration range of 35–2,200 ng/g
lw and 58–5,700 ng/g lw in the low and mod-
erate/high pilot whale blubber consumption
groups, respectively, while ΣPCB ranges are
150–9,000 ng/g lw and 280–22,000 ng/g lw.
Discussion
This study amplifies previous evidence that
increased PCB exposures occur in the Faroe
Islands. In addition, new evidence is pre-
sented that OH-PCBs occur in conjunction
with the PCB congeners normally observed as
a result of dietary exposure to OHSs. As
recently reported, likely sources of OHS
exposures in the Faroe Islands are pilot whale
blubber and muscle, wild birds, and bird eggs
(22,23). This study did not attempt to quan-
tify lifetime intakes of blubber or alternative
exposure sources.
Instead, subjects were divided into two
groups in relation to their recent consump-
tion of pilot whale blubber, the only dietary-
related parameter available describing
potentially different exposures to persistent
organic pollutants and their metabolites. This
division provided reasonable numbers of sub-
jects in each category. When more information
becomes available on OHS concentrations in
Faroese subsistence foods and the actual intake
of these foods, it will be possible to improve
the exposure assessment. Nonetheless, the
present study shows a major difference in
exposures of OH-PCBs and PCBs depending
on the recent intake of pilot whale blubber.
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Figure 1. Gas chromatogram (GC/ECD) demonstrating the presence of hydroxylated polychlorinated biphenyls (OH-PCBs) in a serum sample from a Faroese
woman with a recent moderate/high pilot whale blubber intake. The concentrations of the six most abundant OH-PCBs [4-OH-CB107, 3-OH-CB153, 4-OH-CB146,
3´-OH-CB138, 4-OH-CB187, and 4-OH-CB193 (IS)] were determined as their corresponding methyl ethers. The structures of the six most abundant OH-PCBs are
superimposed in the ﬁgure.
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Table 3. Concentrations (ng/g lipid weight) of 18 PCB congeners in serum from pregnant women from the
Faroe Islands.
Low (0–1 meals/month) Moderate/high (2–8 meals/month)
Compound Median 80%a Median 80%a
Lipid (%) 0.78 0.67–0.97 0.83 0.64–1.0
Polychlorinated biphenyls
CB118 48 24–460 360 46–780
CB146 28 16–200 210 18–360
CB153 190 130–1,500 1,500 130–3,000
CB105 11 4.2–90 78 12–160
CB138 140 94–1,100 1,100 110–1,900
CB178 13 6.5–94 85 7.0–160
CB187 66 35–520 520 42–1,000
CB183 15 9.8–120 130 12–260
CB167 9.9 5.6–77 68 8.6–120
CB177 17 10–130 140 14–280
CB156 18 11–150 130 13–300
CB157 5.0 2.7–36 37 2.8–75
CB172 7.8 3.9–61 56 3.7–110
CB180 120 67–980 890 61–2,300
CB170 46 27–330 300 24–740
CB196 11 4.3–130 110 2.9–340
CB195 4.8 2.7–35 34 2.9–90
CB194 20 9.1–150 120 8.2–330
ΣPCBb 750 460–5,900 5,900 510–12,000
The PCB congeners are listed in elution order on a DB5 GC-column. 
a80% range (10th–90th percentiles). bSum of the PCBs shown.The major OH-PCBs identified in the
serum samples were 4-OH-CB107, 3-OH-
CB153, 4-OH-CB146, 3´-OH-CB138 and
4-OH-CB187, the latter being the predomi-
nant hydroxylated PCB metabolite. The same
metabolites have previously been reported as
the major OH-PCBs present in human blood
(5,9,12), with 4-OH-CB187 being the most
abundant OH-PCB (12). However, other
studies have reported that 4-OH-CB107 was
the main metabolite (5,12). The OH-PCB
peak pattern is shown in Figure 1. Estimation
of the total OH-PCB concentrations in the
samples indicate that the levels of the five
major OH-PCBs account for 90% of the
compounds. The 80th percentile of OH-
PCBs in the moderate/high consumption
group (36–1,300 ng/g lw) is almost in the
same as the 80th percentile for CB153 in the
low consumption group (130–1,500 ng/g lw;
Tables 2 and 3).
Persistent PCB congeners, such as
CB118, CB138, CB153, and CB187, have
been shown to form OH-PCB metabolites
that are retained in blood (24). Overall, the
ΣOH-PCB concentrations correspond to
about 10% of the ΣPCB concentration in the
blood serum samples, within a range of about
5–20%. This finding agrees with previous
reports at lower OH-PCB/PCB exposures,
where average ratios of 10% (5,12) have been
observed (9). This ratio may possibly be
higher for persons with relatively low levels of
PCB, as indicated in Figure 2. The concen-
tration dependence of the OH-PCB/PCB
ratio indicates a faster elimination of OH-
PCBs in humans at higher levels of PCB
exposures, which may be explained by induc-
tion of phase II enzymes and conjugation
reactions (9). However, the possibility also
exists that dietary habits may influence the
levels of OH-PCB in the body. Marine food
such as pilot whale predominantly contains
persistent PCB congeners and less of the
lower chlorinated and the more rapidly
metabolized PCB congeners. The formation
of the OH-PCBs depends on the metabolism
and differences in metabolic capacity between
individuals and may thus influence the pat-
tern of OH-PCBs and their concentrations
(9,25). Any conclusions in this regard are
hampered by not knowing to what degree the
OH-PCBs are only generated in humans or
whether they are also retained from ingested
food that contains these compounds, as is the
case with eggs (22).
Some toxicologic data have become avail-
able on at least one of the OH-PCBs, 4-OH-
CB107, which is one of the major OH-PCBs
present in the blood (9,12,19). Thus, low-
dose levels of 4-OH-CB107 induce in vivo
disturbances in rats, influencing the estrous
cycle and behavior of the offspring (19).
Current exposure levels of OH-PCBs as deter-
mined in the present study appear to be close
to the levels at which effects were observed in
the rats. This conclusion is based on the
assumption that all halogenated phenolic
compounds are as toxic as 4-OH-CB107, an
assumption that cannot be confirmed or
rejected at this time.
Because of the possible interaction of
OH-PCBs with transthyretine and thyroid
metabolism (18), questions regarding the thy-
roid function have been addressed in the
Faroese studies. In the full cohort of children
born in 1994, thyroid function was assessed
by analysis of serum from the mothers and
from the umbilical cord. No association of
thyroid hormone parameters with PCB expo-
sure was found (7). In a previous cohort, no
association was found between PCB concen-
trations in cord tissue and thyroxine and thy-
roid-stimulating hormone in neonatal serum
(26). The Faroese rely heavily on a seafood
diet, and their iodide intake would therefore
likely be in the optimal range, but it is not
known whether a high iodide intake may pro-
tect against adverse thyroid effects.
Possible adverse health effects have been
considered in clinical examinations of Faroese
children exposed to PCBs and related OHSs
prenatally. Because of concomitant exposure
to methylmercury, any neurotoxic effects of
PCB have not been readily detectable (27).
However, stratified analyses suggest that
PCB-associated neurotoxicity may be more
apparent when exposure to methylmercury is
increased, thus suggesting a possible additive
effect (26). In this regard, ΣPCB was used as
a marker, which reﬂects a complex exposure
that also includes OH-PCBs.
In the serum samples analyzed, CB153 was
the most abundant PCB congener, followed
by CB138 and CB180. The CB153 concen-
trations correlate well with the ΣPCB concen-
tration (r = 0.999), with CB153 accounting
for 25% of the ΣPCBs. Similar correlations
have also previously been reported (28),
although the relative CB153 concentration
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Figure 2. Ratio between OH-PCB metabolites and their corresponding parent PCB congener. Subjects
were divided into groups according to recent pilot whale blubber consumption: low = 0–1 blubber
meals/month and moderate/high = 2–8 blubber meals/month. 
Figure 3. Median concentrations of CB153 (µg/g lipid weight) in human plasma samples are given. Error
bars indicate the 80% range (10th–90th percentiles). The Swedish and Latvian male subjects were divided
into groups according to consumption of fatty fish: low = 0–1 fish meals/month and high ≥ 12 fish
meals/month (12). CB153 concentrations in plasma samples from northern Québec men are expressed as
plasma equivalents and normalized for lipid content (5,29,30). The CB153 levels in women from the Faroe
Islands (present study) were divided into low (0–1 blubber meals/month) and moderate/high (2–8 blubber
meals/month).
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studies (12,28). Undoubtedly, CB153 is a
good indicator for ΣPCB concentrations in
humans, but it is still important to determine
the PCB congener pattern in samples ana-
lyzed because this may indicate origin of
exposure or give other important details
about the exposure.
The CB153 concentrations in the Faroese
serum samples are compared to results
obtained from Sweden, Latvia, and Arctic
Québec in Figure 3. It is notable that the
median level of CB153 in the Faroe Islands
(moderate/high consumption group) is higher
than in any of the other groups and also
exceeds the concentrations from the Inuit
population from northern Québec (5,29,30).
Both the Inuit and the Faroese consume a
seafood diet that includes marine mammals
and seabirds (4,25). However, the ΣPCB
concentrations in blubber from ringed seal
(0.96–5.6 µg/g lw) and beluga whale
(0.31–1.5 µg/g lw), which are part of the
Inuit diet, are only moderately high (25,31)
when compared to ΣPCB levels reported for
pilot whale blubber (10–40 µg/g lw) in the
Faroese diet (32). Thus, even occasional
intake of pilot whale blubber could cause a
substantial exposure to PCBs. In this regard,
it should be noted that the Faroese intake
groups were based on recent dietary habits
and that the Faroese may eat whale blubber
for dinner (usually with whale meat or dried
cod) but also eat thin slices of whale blubber
as a snack.
Because of the potential adverse health
effects caused by OHS contaminants, a rec-
ommendation was issued in 1998 by the
Faroese health authorities: “The best way to
protect fetuses against the potential harmful
effects of PCBs, is if girls and women do not
eat blubber until they have given birth to
their children” (33). The present results, from
samples collected before this statement was
issued, reinforce this recommendation.
However, further investigations are needed to
qualify the present recommendation and to
improve the risk assessment.
The present study shows some high con-
centrations of OH-PCBs and PCBs in
human serum, possibly the highest so far
reported in a population. The main source of
OHS exposures in the Faroe Islands is pilot
whale blubber, but consumption of seabirds
and their eggs may also contribute to expo-
sure, at least in some cases. It is notable that
the Faroese population living in an Atlantic
archipelago far away from OHS pollution
sources show such high OHS burdens as
reported in this study. The PCB exposure
problem is thus not only a matter of the most
contaminated areas, such as the Great Lakes
and the Baltic Sea, but a worldwide problem
linked to dietary habits.
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